Modern Healthcare Technology Holdings (STU:M3L) ROE %: -8.77% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Modern Healthcare Technology Holdings ROE %?

Modern Healthcare Technology Holdings STU:M3L ROE % is -8.77% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 90 Personal Services companies, Modern Healthcare Technology Holdings ranks worse than 72.22% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Modern Healthcare Technology Holdings's annualized net income for the quarter that ended in Mar. 2026 was €-1.84 Mil. Modern Healthcare Technology Holdings's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was €20.93 Mil. Therefore, Modern Healthcare Technology Holdings's annualized ROE % for the quarter that ended in Mar. 2026 was -8.77%.

The historical rank and industry rank for Modern Healthcare Technology Holdings's ROE % or its related term are showing as below:

STU:M3L' s ROE % Range Over the Past 10 Years
Min: -27.04   Med: -7.38   Max: 57.65
Current: -0.93

During the past 13 years, Modern Healthcare Technology Holdings's highest ROE % was 57.65%. The lowest was -27.04%. And the median was -7.38%.

STU:M3L's ROE % is ranked worse than
72.22% of 90 companies
in the Personal Services industry
Industry Median: 6 vs STU:M3L: -0.93

Modern Healthcare Technology Holdings  (STU:M3L) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-1.836/20.9315
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.836 / 48.658)*(48.658 / 59.5535)*(59.5535 / 20.9315)
=Net Margin %*Asset Turnover*Equity Multiplier
=-3.77 %*0.817*2.8452
=ROA %*Equity Multiplier
=-3.08 %*2.8452
=-8.77 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-1.836/20.9315
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1.836 / -1.564) * (-1.564 / 4.042) * (4.042 / 48.658) * (48.658 / 59.5535) * (59.5535 / 20.9315)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.1739 * -0.3869 * 8.31 % * 0.817 * 2.8452
=-8.77 %

Note: The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Modern Healthcare Technology Holdings ROE % Related Terms


Modern Healthcare Technology Holdings ROE % Historical Data

* Premium members only.

The historical data trend for Modern Healthcare Technology Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Healthcare Technology Holdings ROE % Chart

Modern Healthcare Technology Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.13 -9.96 -4.89 -2.72 -0.91

Modern Healthcare Technology Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.26 -17.73 12.62 6.61 -8.77

STU:M3L vs ROL, SCI, HRB: ROE % Comparison

For the Personal Services subindustry, Modern Healthcare Technology Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Healthcare Technology Holdings ROE % vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Modern Healthcare Technology Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Modern Healthcare Technology Holdings's ROE % falls into.



Modern Healthcare Technology Holdings ROE % Calculation

Modern Healthcare Technology Holdings's annualized ROE % for the fiscal year that ended in Mar. 2026 is calculated as

ROE %=Net Income (A: Mar. 2026 )/( (Total Stockholders Equity (A: Mar. 2025 )+Total Stockholders Equity (A: Mar. 2026 ))/ count )
=-0.195/( (22.117+20.631)/ 2 )
=-0.195/21.374
=-0.91 %

Modern Healthcare Technology Holdings's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-1.836/( (21.232+20.631)/ 2 )
=-1.836/20.9315
=-8.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -8.77% mean?
Modern Healthcare Technology Holdings (STU:M3L) has a ROE % of -8.77% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Modern Healthcare Technology Holdings and its competitors. According to the industry distribution chart, Modern Healthcare Technology Holdings ranks #65 out of 90 companies in the Personal Services industry, placing it in the top 72.2%.
Is Modern Healthcare Technology Holdings' ROE % too high?
Modern Healthcare Technology Holdings' current ROE % is -8.77%. Based on the distribution chart, Modern Healthcare Technology Holdings ranks #65 out of 90 companies in the Personal Services industry, which is below the industry midpoint.
How does Modern Healthcare Technology Holdings' ROE % compare to ROL and SCI?
According to the Personal Services industry distribution chart, Modern Healthcare Technology Holdings ranks #65 out of 90 companies for ROE %. This places Modern Healthcare Technology Holdings in the lower half of its industry. The industry median ROE % is 6.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Personal Services company?
The median ROE % among Personal Services companies is 6.00, based on 90 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Modern Healthcare Technology Holdings and its competitors. For the Personal Services industry, the median ROE % is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Healthcare Technology Holdings's current ROE % is -8.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Healthcare Technology Holdings stock overvalued right now?
Based on GuruFocus' analysis, Modern Healthcare Technology Holdings (STU:M3L) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.01 — trading 40% below its estimated fair value. The current ROE % is -8.77%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Modern Healthcare Technology Holdings (STU:M3L), the current ROE % is -8.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modern Healthcare Technology Holdings Business Description

Other Exchanges 00919:Hong Kong
Address 9 Kai Cheung Road, Workshops Nos. 66-68, 6th Floor, Sino Industrial Plaza, Kowloon Bay, Kowloon, Hong Kong, HKG
Modern Healthcare Technology Holdings Ltd is an investment holding company. The company's operating segment includes Beauty and wellness services and Skincare and wellness products. The company generates maximum revenue from Beauty and wellness services segment. The Beauty and Wellness Services segment of the company is engaged in the provision of beauty and wellness services which provides a wide range of health and beauty services, covering skin care, slimming, massage, spa, hair care, manicure, hair removal, makeup, joint care, and privacy care. Geographically, the company derives the maximum of its revenue from Hong Kong and has a presence in Singapore; China, and Australia.